Biophysical Journal 59: 1085-1090 (1991)
© 1991 the Biophysical Society

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fill, M Articles by Nelson, T E Search for Related Content PubMed PubMed Citation Articles by Fill, M Articles by Nelson, T E

Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle.

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

ABSTRACT

Single sarcoplasmic reticulum (SR) Ca2+ release channels were reconstituted from normal and malignant hyperthermic (MH) human skeletal muscle biopsies (2-5 g samples). Conduction, gating properties, and myoplasmic Ca2+ dependence of human SR Ca2+ release channels were similar to those in other species (rabbit, pig). The MH diagnostic procedure distinguishes three phenotypes (normal, MH-equivocal, and MH-susceptible) on the basis of muscle contracture sensitivity to caffeine and/or halothane. Single channel studies reveal that human MH muscles (both MH phenotypes) contain SR Ca2+ release channels with abnormally greater caffeine sensitivity. Muscles from MH-equivocal and MH-susceptible patients appear to contain channels with the same abnormality. Further, our data (n = 115, 21 channels, 11 patients) reveals that human MH muscles (both phenotypes) may contain two populations of SR Ca2+ release channels, possibly corresponding to normal and abnormal isoforms. Thus, whole cell phenotypic variation (MH-equivocal vs. MH-susceptible) arises in muscles containing channels with similar caffeine sensitivity suggesting that human MH does not arise from a single defect. These results have important ramifications concerning (a) correlation of functional and genetic MH studies, (b) identification of other, yet to be determined, factors which may influence MH expression, and (c) characterization of normal SR Ca2+ release channel function by exploring genetic channel defects.

This article has been cited by other articles:

				R. G. Weiss, K. M. S. O'Connell, B. E. Flucher, P. D. Allen, M. Grabner, and R. T. Dirksen Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1094 - C1102. [Abstract] [Full Text] [PDF]

				E. M. Gallant, J. Hart, K. Eager, S. Curtis, and A. F. Dulhunty Caffeine sensitivity of native RyR channels from normal and malignant hyperthermic pigs: effects of a DHPR II-III loop peptide Am J Physiol Cell Physiol, April 1, 2004; 286(4): C821 - C830. [Abstract] [Full Text] [PDF]

				A. Lacampagne, M. G. Klein, C. W. Ward, and M. F. Schneider Two mechanisms for termination of individual Ca2+ sparks in skeletal muscle PNAS, July 5, 2000; 97(14): 7823 - 7828. [Abstract] [Full Text] [PDF]

				T. Yamamoto, R. El-Hayek, and N. Ikemoto Postulated Role of Interdomain Interaction within the Ryanodine Receptor in Ca2+ Channel Regulation J. Biol. Chem., April 14, 2000; 275(16): 11618 - 11625. [Abstract] [Full Text] [PDF]

				R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF]

				M. Richter, L. Schleithoff, T. Deufel, F. Lehmann-Horn, and A. Herrmann-Frank Functional Characterization of a Distinct Ryanodine Receptor Mutation in Human Malignant Hyperthermia-susceptible Muscle J. Biol. Chem., February 21, 1997; 272(8): 5256 - 5260. [Abstract] [Full Text] [PDF]

				F. Zorzato, P. Menegazzi, S. Treves, and M. Ronjat Role of Malignant Hyperthermia Domain in the Regulation of Ca2+ Release Channel (Ryanodine Receptor) of Skeletal Muscle Sarcoplasmic Reticulum J. Biol. Chem., September 13, 1996; 271(37): 22759 - 22763. [Abstract] [Full Text] [PDF]

				T. E. Nelson and I. J. Butler Malignant Hyperthermia: Skeletal Muscle Defect(s) Predisposing to Labile Ca2 + Regulation? J Child Neurol, October 1, 1992; 7(4): 329 - 331. [PDF]

				D. MacLennan and M. Phillips Malignant hyperthermia Science, May 8, 1992; 256(5058): 789 - 794. [Abstract] [PDF]